Dylan Calvin Yu

Dr. Dylan Calvin Yu

orcid

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 January 2026 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
DYDylan Calvin Yu
Dylan Calvin Yu
YAYaser Ahmad
Yaser Ahmad
MRManinder Randhawa
Maninder Randhawa
ARAnand S. Rai
Anand S. Rai
APAritra Paul
Aritra Paul
JKJagadeesh K. Kalavakunta
Jagadeesh K. Kalavakunta
Background: Cardiovascular risk models, such as the Framingham and atherosclerotic cardiovascular disease (ASCVD) calculators, have improved risk prediction but often fail to identify individuals who experience ASCVD events despite low or intermediate predicted risk. This suggests that underrecognized, non-traditional risk factors may contribute significantly to the development of atherosclerosis. Objective: This narrative review synthesizes and summarizes recent evidence on high-yield non-traditional risk factors for atherosclerosis, with a focus on clinically significant, emerging, and applicable contributors beyond conventional frameworks. This review is distinct in that it aggregates a wide array of non-traditional risk factors while also consolidating recent data on ASCVD in more vulnerable populations. Unlike the existing literature, this manuscript integrates in a single comprehensive review various domains of non-traditional atherosclerotic risk factors, including inflammatory, metabolic, behavioral, environmental, and physical pathways. An additional unique highlight in the same manuscript is the discussion of non-traditional risk factors for atherosclerosis in more vulnerable populations, specifically South Asians. We also focus on clinically actionable factors that can guide treatment decisions for clinicians. Results: Key non-traditional risk factors identified include inflammation and biomarker-based risk factors such as C-reactive protein or interleukin-6 levels, metabolic and microbial risk factors, behavioral factors such as E-cigarette use, and environmental or infectious risk factors such as air and noise pollution. We explore certain physical exam findings associated with atherosclerotic burden, such as Frank’s sign and Achilles tendon thickness. Conclusions: Atherosclerosis is a multifactorial process influenced by diverse and often overlooked factors. Integrating non-traditional risks into clinical assessment may improve early detection, guide prevention and personalize care. Future risk prediction models should incorporate molecular, behavioral, and environmental data to reflect the complex nature of cardiovascular disease.

Verified
Journal Article
Open access
PDF file
MRManinder Randhawa
Maninder Randhawa
DYDylan Calvin Yu
Dylan Calvin Yu
ARAnand Rai
Anand Rai
ABAustin Brubaker
Austin Brubaker
OAOsama Ahmed
Osama Ahmed
SKSanthosh K. G. Koshy
Santhosh K. G. Koshy
Background: Ventricular arrhythmias (VAs) represent a high-risk complication of acute myocardial infarction (AMI) and are associated with high morbidity and mortality. Racial and ethnic disparities in the management and in-hospital outcomes of AMI with VAs remain incompletely understood. Methods: Using the National Inpatient Sample, we conducted a retrospective analysis of hospitalizations in which AMI was complicated by VAs from 2002 to 2022. Hospitalizations were stratified by race/ethnicity including White, Black, Hispanic, and other racial/ethnic groups. Baseline characteristics and in-hospital outcomes were compared across groups. Results: We identified 902,398 hospitalizations in which AMI was complicated by VAs, of which 78.2% occurred among White, 9.6% among Black, 6.3% among Hispanic, and 5.9% among patients of other racial/ethnic groups. Compared with White patients, Hispanic (aOR 1.21; CI 1.14–1.28) and patients in other racial/ethnic groups (aOR 1.31; CI 1.24–1.39) had higher odds of in-hospital mortality while Black patients had similar odds. In terms of procedural utilization, Black (aOR 0.65; CI 0.62–0.68), Hispanic (aOR 0.82; CI 0.77–0.86), and other racial/ethnic groups (aOR 0.89; CI 0.85–0.94) all had lower odds of percutaneous coronary intervention (PCI) relative to White patients. Black patients also had lower odds of coronary artery bypass grafting (CABG) (aOR 0.69; CI 0.64–0.74) and implantable cardioverter-defibrillator (ICD) insertion (aOR 0.84; CI 0.74–0.96) compared with White patients during admission. Conclusions: Racial and ethnic disparities exist in the prevalence, management, and in-hospital outcomes of AMI complicated by VAs. Further efforts are needed to address differences in care in this high-risk population.

18 June 2026 in Cancers
Verified
Journal Article
Open access
PDF file
JBJustin Baik
Justin Baik
FKFaizan Khajar
Faizan Khajar
MRManinder Randhawa
Maninder Randhawa
HPHarshank Vishnubhai Patel
Harshank Vishnubhai Patel
APAritra Paul
Aritra Paul
SKSanthosh K. G. Koshy
Santhosh K. G. Koshy
Background: Coronary artery disease (CAD) is an important comorbidity that may increase perioperative cardiovascular risk in major noncardiac surgery. However, data evaluating its impact on outcomes following pancreatic cancer surgery remain limited. This study evaluated inpatient outcomes among patients undergoing pancreatic cancer resection with versus without CAD in the United States. Methods: We performed a retrospective analysis using the National Inpatient Sample (2016–2022). Adult hospitalizations with ICD-10 diagnosis codes for pancreatic cancer and procedure codes for pancreatic resection were identified and stratified by the presence of CAD. The primary outcome was in-hospital mortality. Secondary outcomes included length of stay, hospitalization cost, and complications such as shock, respiratory failure, acute kidney injury, and transfusion. Results: A total of 49,395 hospitalizations were identified, including 6910 (14.0%) with CAD. Patients with CAD were older and had a greater comorbidity burden. In-hospital mortality was similar between groups (2.32% vs. 2.34%). Most complications were comparable, although shock was more frequent in CAD patients (6.66% vs. 5.44%). Length of stay was similar, while hospitalization costs were modestly higher in the CAD cohort. Conclusions: Pre-existing CAD was not associated with increased in-hospital mortality or longer hospitalization following pancreatic cancer surgery despite a greater comorbidity burden.